Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer
Clinical trial NCT01803269 · TERMINATED
Trial details
- NCT number
- NCT01803269
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-16
- Primary completion
- 2016-03-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.